Maximus, Inc. (NYSE:MMS) Shares Sold by MetLife Investment Management LLC

MetLife Investment Management LLC cut its stake in shares of Maximus, Inc. (NYSE:MMS) by 2.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 64,470 shares of the health services provider’s stock after selling 1,642 shares during the quarter. MetLife Investment Management LLC owned about 0.11% of Maximus worth $6,006,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in the company. Assenagon Asset Management S.A. grew its stake in Maximus by 277.0% during the 3rd quarter. Assenagon Asset Management S.A. now owns 878,894 shares of the health services provider’s stock valued at $81,878,000 after purchasing an additional 645,760 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its position in Maximus by 942.9% in the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 323,300 shares of the health services provider’s stock valued at $27,707,000 after buying an additional 292,300 shares during the last quarter. Millennium Management LLC increased its holdings in Maximus by 150.4% in the 2nd quarter. Millennium Management LLC now owns 406,075 shares of the health services provider’s stock worth $34,801,000 after buying an additional 243,890 shares during the period. Algert Global LLC purchased a new position in Maximus during the 2nd quarter worth approximately $12,424,000. Finally, Reinhart Partners LLC. lifted its stake in Maximus by 53.5% during the 2nd quarter. Reinhart Partners LLC. now owns 355,914 shares of the health services provider’s stock valued at $30,502,000 after acquiring an additional 124,095 shares during the period. 97.21% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, insider Michelle F. Link sold 1,363 shares of the firm’s stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $92.56, for a total transaction of $126,159.28. Following the sale, the insider now owns 6,567 shares in the company, valued at approximately $607,841.52. This trade represents a 17.19 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.40% of the company’s stock.

Maximus Stock Up 2.8 %

Shares of MMS opened at $74.50 on Friday. The company has a market capitalization of $4.49 billion, a price-to-earnings ratio of 14.90 and a beta of 0.77. Maximus, Inc. has a 52 week low of $71.75 and a 52 week high of $93.97. The stock’s 50-day moving average price is $86.50 and its 200-day moving average price is $87.57. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.59.

Maximus Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Saturday, November 30th. Stockholders of record on Friday, November 15th were paid a dividend of $0.30 per share. The ex-dividend date was Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.61%. Maximus’s payout ratio is 24.00%.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut shares of Maximus from a “buy” rating to a “hold” rating in a report on Thursday.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.